{"title": "Clinical features and laboratory inspection of novel coronavirus pneumonia (COVID-19) in Xiangyang, Hubei", "doi": "10.1101/2020.02.23.20026963", "citation_id": "2020.02.23.20026963v1", "date": "2020-02-25", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.23.20026963", "abstract": "<p>Background: Since December 2019, a novel coronavirus pneumonia (COVID-19)\nrapidly spread in China, reached multiple continents currently.We aimed to reveal the\ninfectious characteristics of COVID-19 that provide more information for the research\nof novel coronavirus.\nMethods: We performed a retrospective study on the clinical characteristics of 128\nCOVID-19 cases with laboratory-confirmed from Xiangyang No 1 Hospitalad during\nJanuary 2020 to 16 February 2020.\nResults: Female patients account for 53.1%. The aged below 20 years that\naccounts for 1.6% of overall patients. The aged in 21~50, 51~65, over 66 years were\naccounts for 44.5%, 35.1%,18.8%, respectively. In the difference age spectrum, all\nsevere groups compared with non-severe groups were difference significantly ( P &lt;\n0.01 ). Fever ( 89.8% ) and Cough ( 67.2% ) were common clinical symptoms. The\nrate of patients with sore throats (14.1%) was rare. The rate of chest computed\ntomography scan showing ground glass opacity in overall, non-severe, severe groups\nwere 63.3%, 60.7%, 76.2%, respectively. White blood cell counts in the normal range\nof overall patients, but severe group patients were increased significantly ( P &lt; 0.01).\nLymphocytes of overall patients were decreased. Alanine transaminase (ALT) and\naspartate transaminase (AST) in the normal range of overall patients, but its were\nelevated in the severe group. Creatinine (CR) and blood urea nitrogen (BUN) of\noverall patients in the normal range. C-reactive protein (CRP) level of all patients\nwere increased markedly, but it in the severe group was significantly higher than that\nin the non-severe group ( P &lt; 0.01 ).\nConclusions: Our data provide more information that advanced age, lower\nlymphocytes levels at the diagnosed COVID-19 patients may be a risk factor for\nunfavourable prognosis. The white blood cells and C-reactive protein level elevated in\nsevere COVID-19 patients may be accompanying bacterial infection. 2019-nCov may\nbe carries a risk factor of impaired liver and kidney function.</p>", "twitter_description": "Background: Since December 2019, a novel coronavirus pneumonia (COVID-19) rapidly spread in China, reached multiple continents currently.We aimed to reveal the infectious characteristics of COVID-19 that provide more information for the research of novel coronavirus. Methods: We performed a retrospective study on the clinical characteristics of 128 COVID-19 cases with laboratory-confirmed from Xiangyang No 1 Hospitalad during January 2020 to 16 February 2020. Results: Female patients account for 53.1%. The aged below 20 years that accounts for 1.6% of overall patients. The aged in 21~50, 51~65, over 66 years were accounts for 44.5%, 35.1%,18.8%, respectively. In the difference age spectrum, all severe groups compared with non-severe groups were difference significantly ( P < 0.01 ). Fever ( 89.8% ) and Cough ( 67.2% ) were common clinical symptoms. The rate of patients with sore throats (14.1%) was rare. The rate of chest computed tomography scan showing ground glass opacity in overall, non-severe, severe groups were 63.3%, 60.7%, 76.2%, respectively. White blood cell counts in the normal range of overall patients, but severe group patients were increased significantly ( P < 0.01). Lymphocytes of overall patients were decreased. Alanine transaminase (ALT) and aspartate transaminase (AST) in the normal range of overall patients, but its were elevated in the severe group. Creatinine (CR) and blood urea nitrogen (BUN) of overall patients in the normal range. C-reactive protein (CRP) level of all patients were increased markedly, but it in the severe group was significantly higher than that in the non-severe group ( P < 0.01 ). Conclusions: Our data provide more information that advanced age, lower lymphocytes levels at the diagnosed COVID-19 patients may be a risk factor for unfavourable prognosis. The white blood cells and C-reactive protein level elevated in severe COVID-19 patients may be accompanying bacterial infection. 2019-nCov may be carries a risk factor of impaired liver and kidney function.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis work was financially supported by grants from the Youth development fund of Xiangyang No.1 Hospital.\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nAll authors declare no competing interests of this study.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.23.20026963v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.23.20026963v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.23.20026963v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/25/2020.02.23.20026963.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. This pre-print is available under a Creative Commons License (Attribution-NonCommercial-NoDerivs 4.0 International), CC BY-NC-ND 4.0, as described at http://creativecommons.org/licenses/by-nc-nd/4.0/", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.23.20026963v1", "access_rights": "restricted", "authors": ["Weiliang Cao"]}